Incremental Hemodialysis: The TwoPlus Trial

Status Recruiting

Clinical Trial Summary

This study is to prospectively compare clinical effectiveness between clinically- matched incremental hemodialysis and conventional hemodialysis in patients with incident kidney dysfunction requiring dialysis and residual kidney function. The study will enroll 350 patients on chronic hemodialysis and 140 caregivers of enrolled patients. Patients will be randomized in 1:1 ratio to either incremental start hemodialysis or conventional hemodialysis. Caregivers will be followed along with patients for an average period of 2 years post randomization.

Clinical Trial Description

This study will analyze the effects of differentiated care with individualized hemodialysis on patient health related quality of life, fatigue, employment, and caregiver burden in patients with Kidney dysfunction requiring dialysis (KDRD) and appreciable kidney function. This study will compare the outcomes in survival, hospitalization, preservation of the kidney function and quality of life between hemodialysis tailored to each patient needs (incremental) and conventional hemodialysis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05828823
Study type	Interventional
Source	Wake Forest University Health Sciences
Contact	Denisse A Funes
Phone	336-716-8671
Email	dfunes@wakehealth.edu
Status	Recruiting
Phase	N/A
Start date	February 26, 2024
Completion date	March 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02235571` - iChoose Decision Kidney Aid for End-Stage Renal Disease Patients	N/A
Active, not recruiting	`NCT05027074` - Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)	Phase 2
Completed	`NCT03582592` - Fluid Distribution Timetable on Adherence to Fluid Restriction of Patients With End-Stage Renal Disease on Hemodialysis	N/A
Completed	`NCT02694068` - Biological Determinants of Peritoneal Dialysis
Not yet recruiting	`NCT02832505` - Applications of MRI in Kidney Disease
Not yet recruiting	`NCT02590081` - Effect of Sodium Rinsing Fluid on Blood Pressure and Interdialytic Weight Change in Hemodialysis Patients	Phase 4
Completed	`NCT01859884` - Optimizing Kidney Transplant Informed Consent	N/A
Completed	`NCT00509236` - Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)	Phase 3
Completed	`NCT02009514` - Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients	Phase 4
Not yet recruiting	`NCT06377293` - Effect of Dialysis-specific Therapeutic Diet on Biochemical Parameters in Dialysis Patients	N/A
Completed	`NCT01528800` - Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients	Phase 2
Completed	`NCT01863914` - Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula	Phase 2
Withdrawn	`NCT06030050` - Animal Assisted Intervention for Hemodialysis Outpatients	N/A
Completed	`NCT04610593` - Effects of a Mindfulness-based Intervention in Stress, Pain and Quality of Life in People Undergoing Hemodialysis	N/A
Recruiting	`NCT05931276` - CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes	Phase 3
Completed	`NCT00143741` - Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers	Phase 1
Active, not recruiting	`NCT02755610` - Check List to Improve Patient Self-care and Product Defect Report in Continuous Ambulatory Peritoneal Dialysis	N/A
Recruiting	`NCT03142529` - Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease	Phase 1/Phase 2
Completed	`NCT02342119` - Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation	N/A
Recruiting	`NCT05614115` - Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD	Phase 1